The UK at the Forefront of Innovative Drug-Radiotherapy Combination Clinical Trials: Introducing the CONCORDE Platform. (2020)
Attributed to:
Novel strategies to improve the effectiveness of radiation and targeted therapies in lung cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.clon.2020.02.003
PubMed Identifier: 32107107
Publication URI: http://europepmc.org/abstract/MED/32107107
Type: Journal Article/Review
Volume: 32
Parent Publication: Clinical oncology (Royal College of Radiologists (Great Britain))
Issue: 6
ISSN: 0936-6555